Cargando…
Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients
INTRODUCTION: Fractalkine is a chemokine implicated as a mediator in a variety of inflammatory conditions. Knowledge of fractalkine release in patients presenting with infection to the Intensive Care Unit (ICU) is highly limited. The primary objective of this study was to establish whether plasma fr...
Autores principales: | Hoogendijk, Arie J., Wiewel, Maryse A., van Vught, Lonneke A., Scicluna, Brendon P., Belkasim-Bohoudi, Hakima, Horn, Janneke, Zwinderman, Aeilko H., Klein Klouwenberg, Peter M. C., Cremer, Olaf L., Bonten, Marc J., Schultz, Marcus J., van der Poll, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658804/ https://www.ncbi.nlm.nih.gov/pubmed/26603530 http://dx.doi.org/10.1186/s13054-015-1125-0 |
Ejemplares similares
-
The host response in critically ill sepsis patients on statin therapy: a prospective observational study
por: Wiewel, Maryse A., et al.
Publicado: (2018) -
Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients
por: van Vught, Lonneke A., et al.
Publicado: (2016) -
Risk factors, host response and outcome of hypothermic sepsis
por: Wiewel, Maryse A., et al.
Publicado: (2016) -
Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis
por: Wiewel, Maryse A., et al.
Publicado: (2016) -
The leukocyte non-coding RNA landscape in critically ill patients with sepsis
por: Scicluna, Brendon P, et al.
Publicado: (2020)